USA: +1 312-376-8303
EU: +44 208-144-9523
info@cognitivemarketresearch.com
D&B D-U-N-S No : 85-356-3074
Home Videos

End Stage Renal Disease Treatment Market Insights Video

According to Cognitive Market Research, the global End Stage Renal Disease Treatment market size will be USD 115215.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 14.20% from 2024 to 2031.

  • North America held the major market share for more than 40% of the global revenue with a market size of USD 46086.20 million in 2024 and will rise at the compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.
  • Europe accounted for a market share of over 30% of the global revenue with a market size of USD 34564.65 million.
  • Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 26499.57 million in 2024 and will rise at the compound annual growth rate (CAGR) of 16.2% from 2024 to 2031.
  • Latin America had a market share of more than 5% of the global revenue with a market size of USD 5760.78 million in 2024 and will rise at the compound annual growth rate (CAGR) of 13.6% from the year 2024 to 2031.
  • Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 2304.31 million in 2024 and will rise at the compound annual growth rate (CAGR) of 13.9% from 2024 to 2031.
  • The public hospitals category is the fastest growing segment of the End Stage Renal Disease Treatment industry

 

Read Report Request Sample
Previous
VideoNext
Video